AWAITS: A Web-based E-health Application for Active Illicit Opioid Users (AWAITS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03402672|
Recruitment Status : Completed
First Posted : January 18, 2018
Last Update Posted : April 10, 2019
The purpose of this research study is to:
- assess how participants like the AWAITS e-health application as measured by their feedback on the intervention
- test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies.
- assess the proportion of participants who accept a list of local treatment providers
- test the impact of AWAITS on interest in being tested for HCV/HIV.
|Condition or disease||Intervention/treatment||Phase|
|Opioid-use Disorder IV Drug Usage Overdose Drug Addiction Substance Use Disorders||Other: self-administered, e-health application||Not Applicable|
The pre-post study of AWAITS will: 1) assess the acceptability of AWAITS as measured by participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest in being tested for HCV/HIV.
The acceptability of AWAITS will be assessed with a feedback form which includes questions about how helpful the intervention was (scale of 1-4), what the patient liked most and least about the intervention, and any suggestions for improving it. The average (and standard deviation) for the rated helpfulness of the intervention will be derived and the qualitative data about what they liked most and least about the intervention and suggestions for improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list of local MAT treatment providers will be calculated.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Web-based E-health Application for Active Illicit Opioid Users Providing Information About Overdose and Infection Risk Factors and Encouraging HCV/HIV Testing and Medication Assisted Treatment Seeking|
|Actual Study Start Date :||November 8, 2017|
|Actual Primary Completion Date :||June 21, 2018|
|Actual Study Completion Date :||June 21, 2018|
Participants who meet criteria will receive the AWAITS self-administered, e-health application intervention.
Other: self-administered, e-health application
AWAITS is a self-administered, e-health application and includes short videos in which patients who are successfully engaged in MAT discuss what they wish they had known about MAT when they were actively using. The intervention is designed to maximize "scalability" - the administration would entail handing an electronic device (e.g., tablet, laptop, etc.) to an individual who would then self-administer the intervention.
- 3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT) [ Time Frame: Day 1 ]To test the impact of AWAITS on knowledge about opioid overdose
- Feedback on AWAITS [ Time Frame: Day 1 ]To assess the acceptability of the intervention
- Acceptance of list of MAT providers [ Time Frame: Day 1 ]Assess relative interest in MAT post-AWAITS
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03402672
|United States, Ohio|
|University of Cincinnati Addiction Sciences Division|
|Cincinnati, Ohio, United States, 45229|
|Principal Investigator:||Theresa Winhusen, PhD||University of Cincinnati|